Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Forlenza

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Endocrine Reviews|September 6, 2022
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical PracticeMoshe Phillip, Revital Nimri, Richard M Bergenstal, et al.
Journal of Diabetes Science and Technology|March 29, 2022
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician RatingsDavid C Klonoff, Jing Wang, David Rodbard, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Diabetes Technology & Therapeutics|June 5, 2026
Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe UseSatish K Garg, Halis K Akturk, Samita Garg, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Diabetes Technology & Therapeutics|August 18, 2025
Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One SensorLaura M Nally, Jennifer L Sherr, Satish K Garg, et al.
Diabetes Care|June 9, 2022
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical TrialJennifer L Sherr, Bruce W Bode, Gregory P Forlenza, et al.
Endocrine Reviews|September 6, 2022
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical PracticeMoshe Phillip, Revital Nimri, Richard M Bergenstal, et al.
Journal of Diabetes Science and Technology|March 29, 2022
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician RatingsDavid C Klonoff, Jing Wang, David Rodbard, et al.
Pageof 15